Factors associated with mortality after breast cancer metastasis

[1]  A. Ording,et al.  Comorbidity and survival of Danish breast cancer patients from 2000–2011: a population-based cohort study , 2013, Clinical epidemiology.

[2]  V. Tjan-Heijnen,et al.  Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[3]  L. Esserman,et al.  Hypertension is an independent predictor of survival disparity between African‐American and white breast cancer patients , 2009, International journal of cancer.

[4]  T. Ahern,et al.  Impact of Acquired Comorbidities on All-Cause Mortality Rates Among Older Breast Cancer Survivors , 2009, Medical care.

[5]  M. Stockler,et al.  Third consensus on medical treatment of metastatic breast cancer. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  E. Sellier,et al.  Analysis of the effect of age on the prognosis of breast cancer , 2009, Breast Cancer Research and Treatment.

[7]  D. Reidpath,et al.  Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran , 2009, BMC Cancer.

[8]  M. Namer,et al.  Prognostic factors in 1,038 women with metastatic breast cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  B. Sternfeld,et al.  Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer , 2008, Cancer Causes & Control.

[10]  David W. Hosmer,et al.  Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .

[11]  B. Zakotnik,et al.  Risk factors for late relapse and death in patients with early breast cancer. , 2008, Neoplasma.

[12]  H. Sørensen,et al.  Comorbidity and survival of Danish breast cancer patients from 1995 to 2005 , 2007, British Journal of Cancer.

[13]  L. Siminoff,et al.  Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer , 2007, Breast Cancer Research and Treatment.

[14]  H. Verkooijen,et al.  Social class is an important and independent prognostic factor of breast cancer mortality , 2006, International journal of cancer.

[15]  C. Johansen,et al.  The relation between socioeconomic and demographic factors and tumour stage in women diagnosed with breast cancer in Denmark, 1983–1999 , 2006, British Journal of Cancer.

[16]  X. Shu,et al.  Association of overweight with breast cancer survival. , 2006, American journal of epidemiology.

[17]  P. Wingo,et al.  Body Mass and Mortality After Breast Cancer Diagnosis , 2005, Cancer Epidemiology Biomarkers & Prevention.

[18]  S. Loi,et al.  Obesity and Outcomes in Premenopausal and Postmenopausal Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[19]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[20]  Y. Shyr,et al.  Effect of Race on Long-Term Survival of Breast Cancer Patients: Transinstitutional Analysis from an Inner City Hospital and University Medical Center , 2005, The American surgeon.

[21]  P. Karlsson,et al.  Socio-economic factors and breast cancer survival – a population-based cohort study (Sweden) , 2005, Cancer Causes & Control.

[22]  R. Rouzier,et al.  Breast cancer with synchronous metastases: trends in survival during a 14-year period. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  G. Nagel,et al.  The impact of comorbidity on the survival of postmenopausal women with breast cancer , 2004, Journal of Cancer Research and Clinical Oncology.

[24]  A. Goldhirsch,et al.  Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  G. Bastert,et al.  Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis , 2000, Breast Cancer Research and Treatment.

[26]  Ana Lluch,et al.  Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients , 1999, Breast Cancer Research and Treatment.

[27]  V. Valero,et al.  What is the prognosis of patients with operable breast cancer (BC) five years after diagnosis? , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.

[29]  Jenny C. Chang,et al.  Survival of patients with metastatic breast carcinoma , 2003, Cancer.

[30]  Cathy J Bradley,et al.  Race, socioeconomic status, and breast cancer treatment and survival. , 2002, Journal of the National Cancer Institute.

[31]  P. Dombernowsky,et al.  Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[32]  B. Asselain,et al.  Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer. , 2000, European journal of cancer.

[33]  B. Hankey,et al.  Surveillance, Epidemiology, and End Results Program , 1999 .

[34]  Judith D. Goldberg,et al.  Applied Survival Analysis , 1999, Technometrics.

[35]  M. Narabayashi,et al.  Construction and validation of a practical prognostic index for patients with metastatic breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  R. Hiatt,et al.  Comorbidity and breast cancer survival: a comparison between black and white women. , 1996, Annals of epidemiology.

[37]  P. Hamet.  Cancer and hypertension. An unresolved issue. , 1996, Hypertension.

[38]  P. Wingo,et al.  Cancer statistics, 1995 , 1995, CA: a cancer journal for clinicians.

[39]  S. Hilsenbeck,et al.  Survival after first recurrence of breast cancer. The miami experience , 1992, Cancer.

[40]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[41]  R. Gelman,et al.  Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[43]  R. Gelber,et al.  Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[45]  T. Powles,et al.  An analysis of possible prognostic features of long term and short term survivors of metastatic breast cancer. , 1986, European journal of cancer & clinical oncology.

[46]  G. Hortobagyi,et al.  Multivariate analysis of prognostic factors in metastatic breast cancer. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  G. Hortobagyi,et al.  Prognostic factors in metastatic breast cancer treated with combination chemotherapy. , 1979, Cancer research.

[48]  D. Rubin,et al.  Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .

[49]  S. Cutler,et al.  Classification of patients with disseminated cancer of the breast , 1969, Cancer.

[50]  M. Laberge.  [Cancer of the breast]. , 1961, Laval medical.

[51]  C. Eggers,et al.  CANCER OF THE BREAST , 1941, Annals of surgery.